— Know what they know.
Not Investment Advice

RPRX Dividends

Royalty Pharma plc
1W: -1.8% 1M: -9.4% 3M: +0.4% YTD: +47.9% 1Y: +58.2% 3Y: +127.9% 5Y: +70.8%
$57.16
-0.47 (-0.82%)
 
Weekly Expected Move ±3.2%
$53 $55 $57 $59 $61
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 40 · $25.3B mcap · 415M float · 0.803% daily turnover · Short 44% of daily vol

Dividend Overview

1.62%
Dividend Yield
$0.93
Annual Dividend
48.9%
Payout Ratio
13.4%
FCF Payout
1
Yr Increase Streak
1.03%
Buyback Yield
2.31%
Total Return
7.32%
Chowder Number

Annual Dividend History

Quarterly Payment History

Shareholder Returns: Dividends vs Buybacks

Full Payment History (25 payments)
Ex-DateAmountAdj. AmountYieldFrequency
2026-08-14 $0.2350 $0.2350 157.85% Quarterly
2026-05-15 $0.2350 $0.2350 172.19% Quarterly
2026-02-20 $0.2350 $0.2350 198.36% Quarterly
2025-11-14 $0.2200 $0.2200 224.72% Quarterly
2025-08-15 $0.2200 $0.2200 239.34% Quarterly
2025-05-16 $0.2200 $0.2200 252.79% Quarterly
2025-02-21 $0.2200 $0.2200 254.34% Quarterly
2024-11-15 $0.2100 $0.2100 326.85% Quarterly
2024-08-16 $0.2100 $0.2100 305.48% Quarterly
2024-05-16 $0.2100 $0.2100 294.12% Quarterly
2024-02-15 $0.2100 $0.2100 269.73% Quarterly
2023-11-16 $0.2000 $0.2000 301.55% Quarterly
2023-08-17 $0.2000 $0.2000 269.90% Quarterly
2023-05-18 $0.2000 $0.2000 231.94% Quarterly
2023-02-15 $0.2000 $0.2000 204.30% Quarterly
2022-11-17 $0.1900 $0.1900 179.54% Quarterly
2022-08-18 $0.1900 $0.1900 167.53% Quarterly
2022-05-19 $0.1900 $0.1900 181.00% Quarterly
2022-02-17 $0.1900 $0.1900 176.41% Quarterly
2021-11-18 $0.1700 $0.1700 161.98% Quarterly
2021-08-19 $0.1700 $0.1700 169.75% Quarterly
2021-05-19 $0.1700 $0.1700 159.96% Quarterly
2021-02-18 $0.1700 $0.1700 101.10% Quarterly
2020-11-19 $0.1500 $0.1500 72.32% Quarterly
2020-09-14 $0.1500 $0.1500 37.67% Quarterly

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms